Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,225 | -12,519 | -3,541 | -2,667 | -1,710 |
| Depreciation Amortization | 6 | 7 | 3 | 2 | 1 |
| Accounts payable and accrued liabilities | -5 | -1,167 | 27 | 338 | 255 |
| Other Working Capital | -884 | -1,046 | -233 | 564 | 493 |
| Other Operating Activity | 218 | 9,898 | 52 | -281 | -221 |
| Operating Cash Flow | $-2,889 | $-4,827 | $-3,691 | $-2,044 | $-1,182 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -577 | N/A | N/A | N/A |
| Net Acquisitions | N/A | 1,342 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -200 | 0 | 0 |
| Investing Cash Flow | $N/A | $765 | $-200 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 12,560 | 6,488 | 626 | 655 |
| Other Financing Activity | 0 | -222 | -222 | -222 | -110 |
| Financing Cash Flow | $N/A | $12,338 | $6,266 | $404 | $546 |
| Beginning Cash Position | 10,710 | 2,435 | 2,435 | 2,435 | 2,435 |
| End Cash Position | 7,821 | 10,710 | 4,810 | 795 | 1,798 |
| Net Cash Flow | $-2,889 | $8,275 | $2,375 | $-1,640 | $-636 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,889 | -4,827 | -3,691 | -2,044 | -1,182 |
| Capital Expenditure | N/A | -577 | N/A | N/A | N/A |
| Free Cash Flow | -2,889 | -5,404 | -3,691 | -2,044 | -1,182 |